Not financial advice · For informational purposes only
Not financial advice · For informational purposes only
Immuneering Corporation Class A Common Stock (IMRX) trades at $4.40, +5.52% on the day (open $4.22, high $4.41, low $4.20, volume 0.76M shares). The company operates in the pharmaceutical preparations sector. Current market cap is $269.79M.
ArbibX runs Claude AI across a curated universe of liquid US stocks every hour, surfacing the 15 most actionable picks with confidence scores, target prices, and risk notes. The terminal also includes a sector heatmap, watchlists with price alerts, portfolio tracking with AI grading, and a built-in conversational AI that answers questions about any ticker using live market data.
What is the current price of IMRX?
IMRX (Immuneering Corporation Class A Common Stock) is currently trading at $4.40, up 5.52% on the day. Pricing updates in real time on ArbibX during market hours.
Where can I find AI analysis for IMRX?
ArbibX runs Claude AI across a wide universe of US stocks and surfaces the most actionable picks in the AI Top 15 tab. For a question-and-answer style analysis on IMRX specifically, use the in-app "Ask Claude" assistant — it sees the live price, sector, and your portfolio context, and replies with reasoning grounded in today's numbers.
Is IMRX a buy?
Whether IMRX is a buy depends on your investment goals, time horizon, and risk tolerance. Use ArbibX's AI analysis, the 90-day chart, technical indicators, news feed, and the earnings calendar to make an informed decision. Always do your own research and consider consulting a licensed advisor before investing.
Not financial advice · For informational purposes only · Data via Polygon.io